SCHEMBL6916852

SCHEMBL6916852

COP(=O)(OC)C(C)(C)C(=O)C=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.55
GABBR1 Q9UBS5 2/20 0.55
GPR55 Q9Y2T6 1/20 0.46
TNFRSF1A P19438 1/20 0.44
PTGS1 P23219 4/20 0.43
PTGS2 P35354 4/20 0.43
HMGCR P04035 2/20 0.43
NR1I2 O75469 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX5 P09917 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTT P42858 1/20 0.40
EEF2K O00418 1/20 0.39
SRC P12931 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
EGFR P00533 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7060718 0.88 TNFRSF1A (0.49) GABBR2GABBR1TNFRSF1ACYP1A2CYP2C9
SCHEMBL7060721 0.88 TNFRSF1A (0.49) GABBR2GABBR1TNFRSF1ACYP1A2CYP2C9
SCHEMBL9276670 0.85 HMGCR (0.55) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL9276664 0.85 HMGCR (0.55) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL7065928 0.84 CYP1A2 (0.53) PTGS1PTGS2CYP1A2CYP2C9ALOX5
SCHEMBL7065924 0.84 CYP1A2 (0.53) PTGS1PTGS2CYP1A2CYP2C9ALOX5
SCHEMBL6918935 0.84 GABBR2 (0.50) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL7065247 0.84 GABBR2 (0.50) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL6918934 0.84 GABBR2 (0.50) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL7065244 0.84 GABBR2 (0.50) GABBR2GABBR1GPR55TNFRSF1APTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026245-A2 SUBSTITUTED PHOSPHONATE COMPOUNDS HAVING BONE ANABOLIC ACTIVITY ILEX ONCOLOGY RESEARCH, SARL (CH) 2004-04-01 WO disclosed